These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30587868)

  • 21. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus.
    Nibu K; Sugasawa M; Asai M; Ichimura K; Mochiki M; Terahara A; Kawahara N; Asato H
    Cancer; 2002 Mar; 94(5):1476-82. PubMed ID: 11920504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy in late elderly (aged 75 or older) patients with paranasal sinus carcinoma: a single institution experience.
    Doi H; Kitajima K; Tanooka M; Terada T; Noguchi K; Takada Y; Fujiwara M; Ishikura R; Kamikonya N; Hirota S
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4485-4492. PubMed ID: 27314860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.
    Wang Y; Yang R; Zhao M; Guo W; Zhang L; Zhang W; Wang X
    World J Surg Oncol; 2020 May; 18(1):90. PubMed ID: 32375789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy.
    Hayashi Y; Osawa K; Nakakaji R; Minamiyama S; Ohashi N; Ohya T; Iida M; Iwai T; Ozawa T; Oguri S; Koizumi T; Hirota M; Kioi M; Hata M; Mitsudo K
    Head Neck; 2019 Jun; 41(6):1777-1784. PubMed ID: 30694002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer.
    Samant S; Robbins KT; Vang M; Wan J; Robertson J
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):948-55. PubMed ID: 15313865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
    Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
    Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
    Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
    Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy.
    Shimizu M; Mitsudo K; Koike I; Taguri M; Iwai T; Koizumi T; Oguri S; Kioi M; Hirota M; Inoue T; Tohnai I
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):239-47. PubMed ID: 26768076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy.
    Enomoto K; Inohara H; Higuchi I; Hamada K; Tomiyama Y; Kubo T; Hatazawa J
    Mol Imaging Biol; 2008; 10(4):224-9. PubMed ID: 18528731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
    Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M
    Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
    Kim BK; Kang WJ; Kim JK; Seong J; Park JY; Kim DY; Ahn SH; Lee DY; Lee KH; Lee JD; Han KH
    Cancer; 2011 Oct; 117(20):4779-87. PubMed ID: 21469082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
    Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
    Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-arterial chemoradiation therapy with weekly low-dose cisplatin for squamous cell carcinoma of the maxillary sinus.
    Kaneko T; Tada Y; Maruya S; Takeishi E; Miura K; Masubuchi T; Fushimi C; Hasegawa H; Kamata S
    Int J Oral Maxillofac Surg; 2015 Jun; 44(6):697-704. PubMed ID: 25843537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).
    Homma A; Nakamura K; Matsuura K; Mizusawa J; Onimaru R; Fukuda H; Fujii M
    Jpn J Clin Oncol; 2015 Jan; 45(1):119-22. PubMed ID: 25332419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.